Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Rivaroxaban 15 mg tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10x14
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Rivaroxaban 15 Tablet is a direct oral anticoagulant (DOAC) that inhibits Factor Xa, a crucial enzyme in the coagulation process. This action helps in preventing the formation of harmful blood clots. The 15 mg strength is typically used in the initial phase of treatment for deep vein thrombosis (DVT) and pulmonary embolism (PE), and provides rapid anticoagulant effect with a fixed dosing schedule. It offers a reliable alternative to traditional vitamin K antagonists, without the need for frequent INR monitoring.
The most common adverse effect is bleeding, which may present as easy bruising, nosebleeds, or gastrointestinal bleeding. Other side effects can include nausea, dizziness, or headache. Rare but serious effects may include hepatic dysfunction or allergic reactions. Patients with renal or hepatic impairment should use caution.
Rivaroxaban 15 mg Tablet is indicated for the initial treatment of acute deep vein thrombosis (DVT) and pulmonary embolism (PE). It may also be prescribed in combination with the 20 mg dose for continued therapy in select patients. The use should be guided by a physician experienced in managing thromboembolic disorders.
This medication must be taken exactly as prescribed. It is contraindicated in patients with active bleeding, significant liver disease, or severe renal impairment. Patients should not discontinue Rivaroxaban abruptly without medical advice, as this may increase the risk of thrombotic events. Concurrent use with other anticoagulants or NSAIDs should be monitored closely due to increased bleeding risk.
Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.
Composition : Rivaroxaban 10 mg tablet
Composition : Rivaroxaban 20 mg tablet
Composition : Rosuvastatin 10 mg tablet
Composition : Rosuvastatin (20mg) tablet
Composition : Rosuvastatin 40 mg tablet
Composition : Rosuvastatin 5mg + fenofibrate 160 mg tablet
Composition : Rosuvastatin 20 mg + aspirin 75 mg tablet
Composition : Rosuvastatin 10 mg + Aspirin 75 mg tablet
Composition : Atorvastatin Calcium I.P. 80mg Tablets
Composition : Atorvastatin Calcium I.P. 10mg + Fenofibrate I.P. 160mg Tablets
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.